22/07/2025
How does NAD+ benefit & improve your health? Re-juvenate, Re-energize your life. Contact Kim J for info & appointments. +60 16 295 0330
Autologous Immunotherapy using Dendritic Cells, Natural Killer Cells & Gamma delta T Cells. May be beneficial for treating Diabetes, Heart Disease, OA, Autism.
Bhulta
Monday | 09:00 - 17:00 |
Tuesday | 09:00 - 17:00 |
Wednesday | 09:00 - 17:00 |
Thursday | 09:00 - 17:00 |
Friday | 09:00 - 17:00 |
Saturday | 09:00 - 13:00 |
Be the first to know and let us send you an email when Targeted Immunotherapy for Cancer posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Targeted Immunotherapy for Cancer:
Immunotherapy, whichworks by manipulating patients own immune system to fight cancer, is a rapidly advancing field of translational science. It has been recognized as ‘breakthrough of the year 2013’ by the journal Science. Cellular immunotherapy takes advantage of activated immune cells including dendritic cells, Natural killer cells, T-cells, etc. for treatment of cancers. Dr William Coley first intentionally tried to use immune system to fight cancer in 1891 when he injected bacterial toxins in a cancer patient. Over the next hundred years, there have been many case reports of spontaneous regression of patients’ cancers, which were attributed to destruction of cancer cells by the immune system. Thus, it appears that the immune system is an intricate variable in the prevention (and possibly even in the formation) of malignant neoplasm. The strategies utilized by the immune system to fight cancer are largely the same methods used to fight infectious diseases. The difference lies in the fact that tumor antigens are human proteins that have been adapted to participate in carcinogenesis while pathogenic antigens are transcribed from their own, foreign genomes. Over the last two decades, a large number of academic institutions and companies have started pursuing cellular immunotherapy approach for treatment of cancer. Both US FDA and EMEA has recently approved (April 2010) autologous cellular immunotherapy product (Provenge) from Dendreon for metastatic castrate-resistant prostate cancer.
Here at Care Centre for Cancer Immunotherapy, we have a team of medical doctors including a visiting oncologist who looks at every cancer patients needs and offer scientific treatments. The goal is to reduce the progression of cancer, curtail the spread of cancer, manage pain and quality of life.